New Research Shows Hologic's BioZorb ... | 合法醫療器材資訊網

2021年2月2日—NewResearchShowsHologic'sBioZorb®MarkerisaSafeAdjuncttoBreast-​ConservingSurgerythatMayBenefitRadiationOncologists, ...

--Large, long-term study published in peer-reviewed journal finds tissue marker can benefit radiation therapy planning and surgical cosmesis--

 MARLBOROUGH, Mass. February 2, 2021 – A newly published study has demonstrated the safety and clinical efficacy of Hologic, Inc.’s (Nasdaq: HOLX) BioZorb® 3D bioabsorbable marker when used as an adjunct to breast-conserving surgery.[i] Published online in the Annals of Surgical Oncology, the BioZorb® Registry is the first large, multi-center study to report 24-month outcomes following implantation of the marker as part of breast-conserving surgery.

The BioZorb marker is a 3D implantable marker consisting of a spiral, bioabsorbable framework embed...